Cargando…
Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451928/ https://www.ncbi.nlm.nih.gov/pubmed/33638868 http://dx.doi.org/10.1111/bcp.14765 |
_version_ | 1784569958101942272 |
---|---|
author | Dijkstra, Jacob A. Veldkamp, Agnes I. Sieswerda, Elske van Agtmael, Michiel |
author_facet | Dijkstra, Jacob A. Veldkamp, Agnes I. Sieswerda, Elske van Agtmael, Michiel |
author_sort | Dijkstra, Jacob A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8451928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84519282021-09-27 Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. Dijkstra, Jacob A. Veldkamp, Agnes I. Sieswerda, Elske van Agtmael, Michiel Br J Clin Pharmacol Commentaries John Wiley and Sons Inc. 2021-02-27 2021-09 /pmc/articles/PMC8451928/ /pubmed/33638868 http://dx.doi.org/10.1111/bcp.14765 Text en © 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Commentaries Dijkstra, Jacob A. Veldkamp, Agnes I. Sieswerda, Elske van Agtmael, Michiel Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title | Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title_full | Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title_fullStr | Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title_full_unstemmed | Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title_short | Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al. |
title_sort | software to predict the right dose for vancomycin in a clinical environment—a commentary on: personalised dosing of vancomycin: a prospective and retrospective comparative quasi‐experimental study by luqman vali et al. |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451928/ https://www.ncbi.nlm.nih.gov/pubmed/33638868 http://dx.doi.org/10.1111/bcp.14765 |
work_keys_str_mv | AT dijkstrajacoba softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal AT veldkampagnesi softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal AT sieswerdaelske softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal AT vanagtmaelmichiel softwaretopredicttherightdoseforvancomycininaclinicalenvironmentacommentaryonpersonaliseddosingofvancomycinaprospectiveandretrospectivecomparativequasiexperimentalstudybyluqmanvalietal |